Emphasizing Patient Centricity and Innovation in Clinical Trials 00:10:00
Dr. Ray is an independent board director and advisor to life sciences companies. Previously, Dr. Ray served as Chief Patient Officer at Biohaven Pharmaceuticals, a public biopharmaceutical company, from March 2022 to December 2022. Prior to his role at Biohaven, he served as Senior Adviser to Bain Capital Life Sciences, an investment company, from February 2021 to March 2022.